BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38679851)

  • 1. Metabolism of highly potent synthetic opioid nitazene analogs: N-ethyl-N-(1-glucuronyloxyethyl) metabolite formation and degradation to N-desethyl metabolites during enzymatic hydrolysis.
    Kanamori T; Okada Y; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT
    Drug Test Anal; 2024 Apr; ():. PubMed ID: 38679851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS).
    Walton SE; Krotulski AJ; Logan BK
    J Anal Toxicol; 2022 Mar; 46(3):221-231. PubMed ID: 34792157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization of protonitazene metabolites, using human liver microsomes, and first application to two urines collected from death cases.
    Ameline A; Gheddar L; Pichini S; Stove C; Aknouche F; Maruejouls C; Raul JS; Kintz P
    Clin Chim Acta; 2024 Jun; 561():119764. PubMed ID: 38844019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole 'nitazene' opioids.
    De Vrieze LM; Walton SE; Pottie E; Papsun D; Logan BK; Krotulski AJ; Stove CP; Vandeputte MM
    Arch Toxicol; 2024 Jun; ():. PubMed ID: 38877156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry.
    Song Y; Yang X; Jiang Y; Tu P
    J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of glucuronides using liver microsomes and their characterization by 1D/2D NMR spectroscopy and mass spectrometry: Application to fentanyl metabolites.
    Kanamori T; Okada Y; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT
    Drug Test Anal; 2024 May; 16(5):447-456. PubMed ID: 37583076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene.
    Taoussi O; Berardinelli D; Zaami S; Tavoletta F; Basile G; Kronstrand R; Auwärter V; Busardò FP; Carlier J
    Arch Toxicol; 2024 Jul; 98(7):2101-2116. PubMed ID: 38582802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-desethyl isotonitazene detected in polydrug users admitted to hospital in Birmingham, United Kingdom.
    Pucci M; Singh Jutley G; Looms J; Ford L
    Clin Toxicol (Phila); 2024 Jan; 62(1):19-25. PubMed ID: 38353737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkoxy chain length governs the potency of 2-benzylbenzimidazole 'nitazene' opioids associated with human overdose.
    Glatfelter GC; Vandeputte MM; Chen L; Walther D; Tsai MM; Shi L; Stove CP; Baumann MH
    Psychopharmacology (Berl); 2023 Dec; 240(12):2573-2584. PubMed ID: 37658878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of a new synthetic opioid tetrahydrofuranylfentanyl in fresh isolated human hepatocytes: Detection and confirmation of ring-opened metabolites.
    Kanamori T; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT
    Drug Test Anal; 2020 Apr; 12(4):439-448. PubMed ID: 31797567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of highly potent synthetic opioid nitazene analogs and their positional isomers.
    Kanamori T; Okada Y; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT
    Drug Test Anal; 2023 Apr; 15(4):449-457. PubMed ID: 36437623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolite Profiling of Ortho-, Meta- and Para-Fluorofentanyl by Hepatocytes and High-Resolution Mass Spectrometry.
    Gundersen POM; Åstrand A; Gréen H; Josefsson M; Spigset O; Vikingsson S
    J Anal Toxicol; 2020 Mar; 44(2):140-148. PubMed ID: 31788682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of liquid chromatography coupled to data-independent acquisition mass spectrometry for the metabolic profiling of N-ethyl heptedrone.
    Mazzarino M; Camuto C; Comunità F; de la Torre X; Stacchini C; Botrè F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122989. PubMed ID: 34678705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass.
    Vandeputte MM; Verougstraete N; Walther D; Glatfelter GC; Malfliet J; Baumann MH; Verstraete AG; Stove CP
    Arch Toxicol; 2022 Jun; 96(6):1865-1880. PubMed ID: 35449307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl.
    Watanabe S; Vikingsson S; Roman M; Green H; Kronstrand R; Wohlfarth A
    AAPS J; 2017 Jul; 19(4):1102-1122. PubMed ID: 28382544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.
    Gandhi AS; Wohlfarth A; Zhu M; Pang S; Castaneto M; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2015 Mar; 7(3):187-98. PubMed ID: 24827428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users.
    McKenzie C; Sutcliffe OB; Read KD; Scullion P; Epemolu O; Fletcher D; Helander A; Beck O; Rylski A; Antonides LH; Riley J; Smith SA; Nic Daeid N
    Forensic Toxicol; 2018; 36(2):359-374. PubMed ID: 29963206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry.
    Öztürk YE; Yeter O; Öztürk S; Karakus G; Ates I; Buyuk Y; Yurdun T
    Drug Test Anal; 2018 Mar; 10(3):449-459. PubMed ID: 28691766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic In Vitro Metabolic Profiling of the OXIZID Synthetic Cannabinoids BZO-4en-POXIZID, BZO-POXIZID, 5F-BZO-POXIZID, BZO-HEXOXIZID and BZO-CHMOXIZID.
    Watanabe S; Baginski S; Iwai T; Matsushita R; Takatsu M; Nakanishi T; Lindbom K; Mckenzie C; Vikingsson S; Kronstrand R; Gréen H; Seto Y
    J Anal Toxicol; 2023 May; 47(5):455-463. PubMed ID: 36857377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism of valerylfentanyl using human liver microsomes and zebrafish larvae.
    Cooman T; Hoover B; Sauvé B; Bergeron SA; Quinete N; Gardinali P; Arroyo LE
    Drug Test Anal; 2022 Jun; 14(6):1116-1129. PubMed ID: 35128825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.